Johnson & Johnson plans Ebola vaccine testing

SHARE Johnson & Johnson plans Ebola vaccine testing

Johnson & Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. The health care products maker said Wednesday that the vaccine being developed by its Janssen Pharmaceutical Companies protects against an Ebola strain that is “highly similar” to the virus that has triggered the current outbreak in West Africa. Johnson & Johnson also plans to test whether its vaccine protects against the version causing the outbreak, which has killed more than 4,500 people.

Read more at Newsfeed.

The Latest
Most of the cuts will be in Illinois-based positions, a company spokesman said.
The teen and another person were in the 100 block of West 79th Street when they each displayed handguns and fired at each other, police said.
Vaughn’s parents argue they’ve lost time and income traveling to see their son in prison. Vaughn is being held in Pinckneyville Correctional Center, serving four life sentences for the murders of his wife and three children.
The action marks a dramatic escalation in law enforcement scrutiny of the former Republican president and comes as he has been laying the groundwork to make another bid for the White House.
Environmental community groups issued a list of demands Monday as they continue to seek answers about the demolition of a smokestack at the former Crawford Coal Plant.